|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2009-8-11
|
|
pubmed:abstractText |
To verify whether enhanced substrate-level phosphorylation increases viability and adenosine 5'-triphosphate (ATP) content of cells with neuropathy, ataxia, and retinitis pigmentosa/maternally inherited Leigh syndrome (NARP/MILS) mitochondrial DNA mutations and ATP synthase dysfunction.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphate,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents, Local,
http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Mitochondrial,
http://linkedlifedata.com/resource/pubmed/chemical/Gramicidin,
http://linkedlifedata.com/resource/pubmed/chemical/Ketoglutaric Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Mitochondrial Proton-Translocating...,
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oligomycins,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-ketoglutaric acid,
http://linkedlifedata.com/resource/pubmed/chemical/neuronal pentraxin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1538-3687
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
951-7
|
|
pubmed:meshHeading |
pubmed-meshheading:19667215-Adenosine Triphosphate,
pubmed-meshheading:19667215-Anti-Infective Agents, Local,
pubmed-meshheading:19667215-Aspartic Acid,
pubmed-meshheading:19667215-C-Reactive Protein,
pubmed-meshheading:19667215-Cell Line,
pubmed-meshheading:19667215-Cell Survival,
pubmed-meshheading:19667215-DNA, Mitochondrial,
pubmed-meshheading:19667215-Energy Metabolism,
pubmed-meshheading:19667215-Gramicidin,
pubmed-meshheading:19667215-Humans,
pubmed-meshheading:19667215-Ketoglutaric Acids,
pubmed-meshheading:19667215-Leigh Disease,
pubmed-meshheading:19667215-Mitochondria,
pubmed-meshheading:19667215-Mitochondrial Proton-Translocating ATPases,
pubmed-meshheading:19667215-Mutation,
pubmed-meshheading:19667215-Nerve Tissue Proteins,
pubmed-meshheading:19667215-Oligomycins,
pubmed-meshheading:19667215-Oxidative Phosphorylation,
pubmed-meshheading:19667215-Retinitis Pigmentosa,
pubmed-meshheading:19667215-Spinocerebellar Degenerations
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/aspartate: a potential new therapy.
|
|
pubmed:affiliation |
Dipartimento di Biochimica "G. Moruzzi", Università di Bologna, Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
